Market cap
$4 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
67.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 34.13 | -- | -- |
| EBIT | 83.45 | 90.75 | 52.21 | 17.34 | 1.26 |
| Net Profit | 77.20 | 87.10 | 50.66 | 17.23 | 0.64 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-24 | Dec-23 | Dec-22 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -5,368.81 | -28,688.06 | -- | -- | -5,368.81 |
| Return on equity
| 104.86 | 39.00 | 683.23 | -293.96 | -74.70 |
| Return on Capital
| 175.53 | 81.65 | 875.69 | -275.62 | -73.47 |
| Return on Assets
| -147.54 | -110.79 | -220.02 | -159.98 | -62.63 |
| Debt to Equity (x)
| -- | -- | -0.14 | -0.35 | 0.03 |
Profitability
ROCE
875.69
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
875.69
|
-275.62
|
-73.47
|
-67.10
|
-51.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
683.23
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
683.23
|
-293.96
|
-74.70
|
-67.67
|
-51.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-220.02
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
-220.02
|
-159.98
|
-62.63
|
-62.60
|
-48.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
--
|
--
|
-5,368.81
|
-70,273.12
|
-10,422.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
--
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
--
|
-22.90
|
34.91
|
-16.32
|
-109.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
50.34
--
Year on year growth in profit after tax
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
50.34
|
-22.44
|
36.01
|
-18.31
|
-110.21
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-0.14
--
Total debt / Net worth
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
-0.14
|
-0.35
|
0.03
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.09
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
-0.09
|
-0.14
|
0.01
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.14
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
2.14
|
0.78
|
4.03
|
10.00
|
18.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
--
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
--
|
--
|
-55.33
|
-711.38
|
-107.78
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
--
|
3,778.38
|
2,890.21
|
1,146.35
|
1,167.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
EV/EBITDA
--
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Aptose Biosciences (APTO)
|
--
|
0.16
|
1.07
|
1.20
|
2.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|